Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TeenCove: mRNA-1273 in Adolescents
NCT04649151Phase 3Completed
- Sponsor
- Moderna Inc
- Start
- Dec 2020
- Primary completion
- Jun 2024
- Modality
- Vaccines & Immunotherapeutics, mRNA Therapeutics
- Countries
- 2
01
Overview
A Phase 3 trial of elasomeran in coronavirus disease 2019 (COVID-19), sponsored by Moderna Inc. Started Dec 2020; status: completed.
02
Drugs
elasomeran
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04649151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04649151.